Knee Pain Phenotypes in the Community Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02098070|
Recruitment Status : Unknown
Verified August 2017 by University of Nottingham.
Recruitment status was: Enrolling by invitation
First Posted : March 27, 2014
Last Update Posted : August 24, 2017
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||40000 participants|
|Official Title:||Knee Pain and Related Health in the Community Study|
|Study Start Date :||September 2014|
|Estimated Primary Completion Date :||September 2018|
|Estimated Study Completion Date :||September 2018|
Knee Pain Population
Participants who have responded to the questionnaire with self-reported pain.
Non-Knee Pain Population
Participants who have responded to the questionnaire, no self-reported pain.
- Knee Pain Phenotypes [ Time Frame: up to 12 months ]The prevalence of the different knee pain phenotypes, provided by specific pain questionnaires. This will include the Intermittent and Constant Osteoarthritis Pain Questionnaire (ICOAP), the Pain Catastrophizing Scale (PCS) and the PainDetect (for neuropathic pain).
- Other Risk Factors [ Time Frame: up to 12 months ]The risk factors for each knee pain phenotype, including age, gender, pain elsewhere, the Hospital Anxiety and Depression Scale (HADS), the pain catastrophizing scale and presence of osteoarthritis risk factors (BMI, finger ratio (2D4D), finger nodes, knee alignment) will be determined from the questionnaires.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02098070
|Nottingham, Nottinghamshire, United Kingdom, NG5 1PB|
|Principal Investigator:||Michael Doherty, MD||University of Nottingham|